Safety and Pharmacokinetics of Intravenous Anidulafungin in Children with Neutropenia at High Risk for Invasive Fungal Infections

Anidulafungin is an echinocandin with activity against Candida species and Aspergillus species. Adult dosages under study are 50 mg/day for esophageal candidiasis and 100 mg/day for invasive candidiasis and aspergillosis. Little is known, however, about the safety and pharmacokinetics of anidulafung...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Benjamin, Daniel K., Driscoll, Timothy, Seibel, Nita L., Gonzalez, Corina E., Roden, Maureen M., Kilaru, Rahki, Clark, Kay, Dowell, James A., Schranz, Jennifer, Walsh, Thomas J.
Format: Artigo
Langue:Inglês
Publié: American Society for Microbiology 2006
Sujets:
Pharmacology
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC1366891/
https://ncbi.nlm.nih.gov/pubmed/16436720
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.50.2.632-638.2006
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires